Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Laure Weijers"'
Autor:
Ann-Marie Chapman, Marieke Schurer, Laure Weijers, Amer Omar, Hiba Lee, Alla Zozulya Weidenfeller, Crispin Ellis, Shaneil Sonecha, Christiane Schneider-Gold
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background Non-dystrophic myotonias (NDMs) comprise muscle chloride and sodium channelopathies due to genetic defects of the CLCN1- and SCN4A-channels. No licensed antimyotonic treatment has been available until approval of mexiletine (NaMus
Externí odkaz:
https://doaj.org/article/2cdb57b2b6a248bc977784e77cd32aaa
Autor:
Alla Zozulya Weidenfeller, Laure Weijers, M. Schurer, Crispin Ellis, Hiba Lee, A.M. Chapman, Shaneil Sonecha, Christiane Schneider-Gold, Amer Omar
Publikováno v:
BMC Neurology
BMC Neurology, Vol 21, Iss 1, Pp 1-16 (2021)
BMC Neurology, Vol 21, Iss 1, Pp 1-16 (2021)
Background Non-dystrophic myotonias (NDMs) comprise muscle chloride and sodium channelopathies due to genetic defects of the CLCN1- and SCN4A-channels. No licensed antimyotonic treatment has been available until approval of mexiletine (NaMuscla®) fo
Autor:
Chad Patel, Silvia Jimenez Merino, M Mtibaa, Carmela Nappi, Francesco Saverio Mennini, Giulia Attinà, Jason Foo, Kirsten H Herrmann, Martin J. Bergman, Christoph Baerwald, Denis Choquette, José Manuel Rodriguez-Heredia, Laure Weijers
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Rheumatology International
Consejería de Sanidad de la Comunidad de Madrid
Rheumatology International
Rheumatoid arthritis (RA) is a chronic inflammatory disorder leading to disability and reduced quality of life. Effective treatment with biologic DMARDs poses a significant economic burden. The Abatacept versus Adalimumab Comparison in Biologic-Naïv